Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial

Eur Heart J. 2024 Apr 9:ehae225. doi: 10.1093/eurheartj/ehae225. Online ahead of print.
No abstract available

Keywords: Anticoagulation; Atrial fibrillation; Atrial high-rate episodes; Bleeding; CHA2DS2-VASc score; Device-detected atrial fibrillation; Kidney function; NOAH-AFNET 6; Stroke.